DarioHealth
DRIO
11 hedge funds and large institutions have $587K invested in DarioHealth in 2017 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 2 closing their positions.
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
38% more funds holding
Funds holding: 8 → 11 (+3)
17% more capital invested
Capital invested by funds: $503K → $587K (+$84K)
0% less ownership
Funds ownership: 0.01% → 0.01% (-0%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
+$125K |
| 2 |
Morgan Stanley
New York
|
+$93.5K |
| 3 |
AIM
Acrospire Investment Management
Chicago,
Illinois
|
+$2.97K |
| 4 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
+$1.49K |
| 5 |
TDC
Thompson Davis & Co
Richmond,
Virginia
|
+$1.49K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$45K |
| 2 |
BA
Bard Associates
Chicago,
Illinois
|
-$17.8K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BA
1
Bard Associates
Chicago,
Illinois
| $352K | -$17.8K | -12 | -4% |
|
|
VKH
2
Virtu KCG Holdings
New York
| $101K | +$125K | +84 | New |
|
|
3
Morgan Stanley
New York
| $75K | +$93.5K | +63 | New |
|
|
PVH
4
Psagot Value Holdings
Tel Aviv,
Israel
| $35K | – | – | – |
|
5
Bank of Montreal
Toronto,
Ontario, Canada
| $15K | – | – | – |
|
|
AG
6
Advisor Group
Phoenix,
Arizona
| $2K | – | – | – |
|
|
LTFS
7
Ladenburg Thalmann Financial Services
Miami,
Florida
| $2K | +$1.49K | +1 | New |
|
|
TDC
8
Thompson Davis & Co
Richmond,
Virginia
| $2K | +$1.49K | +1 | New |
|
|
AIM
9
Acrospire Investment Management
Chicago,
Illinois
| $2K | +$2.97K | +2 | New |
|
10
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | – | – | – |
|
|
11
Goldman Sachs
New York
| – | -$45K | -35 | Closed |
|
|
12
UBS Group
Zurich,
Switzerland
| – | -$6K | -5 | Closed |
|
DRIO Hedge Fund Activity: Q1 2017 in Review
11 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in DarioHealth (DRIO) for Q1 2017, worth a combined $587K — up 17% from $503K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new DRIO positions and 2 closed out — a net gain of 3 holders — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Virtu KCG Holdings, opening a new position worth an estimated $125K. The largest seller was Goldman Sachs, exiting entirely with an estimated $45K sold.
- 11 institutional investors held DarioHealth (DRIO) as of Q1 2017, up from 8 in Q4 2016.
- Funds reported $587K of DarioHealth stock for Q1 2017, up 17% quarter-over-quarter.
- 5 funds opened new DarioHealth positions in Q1 2017 and 2 closed out, a net change of +3 holders.
- The largest DarioHealth buyer in Q1 2017 was Virtu KCG Holdings, an estimated $125K added.
- The largest DarioHealth seller in Q1 2017 was Goldman Sachs, an estimated $45K sold.
Based on aggregated 13F filings for Q1 2017.